Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
RELATED RESEARCH RESOURCES AND LINKS
ListGraphMap
Displaying 1 - 10 of 21 Projects
Project # Contact PI Funding Organization Fiscal Year
Veri-T: A phase 1 Placebo-Controlled Trial of Verdiperstat in FTLD-TDP
PTCG-21-818270 Peter Ljubenkov Alzheimer's Association 2021
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 1b/2a Study of WVE-004 Administered Intrathecally to Patients with C9orf72-associated Amyotrophic Lateral Sclerosis (ALS) or Frontotemporal Dementia (FTD)
ADDF-35 Panzara, Michael Alzheimer's Drug Discovery Foundation 2021
Veri-T: A phase 1 Placebo-Controlled Trial of Verdiperstat in Semantic Variant Primary Progressive Aphasia Due to Underlying FTLD-TDP
1R01AG073482-01 LJUBENKOV, PETER ALEXANDER NIA 2021
AFTD Patient-Focused Drug Development Meeting with the FDA
ADDF-10 Dickinson, Susan Alzheimer's Drug Discovery Foundation 2020
Highly selective detection of tau oligomers in biological fluids for the diagnosis of Alzheimer's Disease
5R42AG058333-03 VOLLRATH, BEN NIA 2020
Highly selective detection of tau oligomers in biological fluids for the diagnosis of Alzheimer's Disease
4R42AG058333-02 VOLLRATH, BEN NIA 2019
Assessing poly(GP) proteins as clinical and pharmacodynamic biomarkers of C9ORF72-associated FTD
2019-005 PETRUCELLI, LEONARD The Association for Frontotemporal Degeneration 2019
Highly selective detection of tau oligomers in biological fluids for the diagnosis of Alzheimers Disease
1R42AG058333-01 VOLLRATH, BEN NIA 2018
Therapeutic regulation of neuroinflammation in underlying FTLD-TDP disorders
GHDI-2013285 Miller, Zachary Alzheimer's Drug Discovery Foundation 2017
Identification of novel biofluid markers of TDP-43 pathology
ARUK-CRF2017B-2 Rachelle Shafei Alzheimer's Research UK 2017